In order to evaluate the involvement of the trimethylamine (TMA) metabolic pathway in equine grass sickness we developed a method that would allow quantification of TMA, two of its precursors (choline and L-carnitine) and its metabolite trimethylamine-N-oxide (TMAO) in plasma and urine from EGS and control horses.
The liquid chromatography tandem mass spectrometry (LC-MS/MS) method was adapted from a method developed by Maksymiuk et al, (1) and has been adapted and validated for measurement in equine plasma and urine on an Acquity I-Class UPLC and QTrap 6500+ mass spectrometer, following derivatisation with tert-butyl bromoacetate. This method can be applied to other species. Limits of quantitation were 5 ng/mL for TMA and 0.25 ng/mL for TMAO, Choline and L-carnitine.
Biological samples (20 μL) and a 15-point calibration standard curve (0.1 – 500 ng range) of the 4 trimethylamine compounds were subject to derivatisation with a solution of tert-butyl bromoacetate (tBBA, Sigma-Aldrich, UK, 124230) (50 μL of 20 μg/mL in acetonitrile) and 2.5% ammonia solution (v/v, 10 μL) for 30 minutes at room temperature. The derivatisation reaction was quenched with 0.5% formic acid (100 μL) in acetonitrile. Only TMA derivatises. The samples were enriched with 13C3-thiamine (40 ng) and transferred to a 96-well filter plate (Isolute Filter+, Biotage, Sweden), positive pressure applied for 5 mins and the eluent collected into a 96-well autosampler plate (Waters, UK). The derivatised compounds were injected (2 μL) and analysed on an Acquity I-Class UPLC (Waters, UK) connected to a QTrap 6500+ (Sciex, UK). The Acquity I-Class was fitted with an Acquity Premier BEH Amide 1.7 µm, Van Guard FIT, 2.1 mm x 100 mm UPLC HILIC column. The mobile phase consisted of mobile phase A – 15 mM ammonium formate in water and mobile phase B – acetonitrile. The chromatographic method started with 10%A, rising to 30%A up to 1.3 mins, held up to 3.8 mins, returning to 10%A by 5 minutes and re-equilibrated for 1 minute, with a total run-time per injection of 6 minutes at a flow rate of 0.5 mL/in and 60oC. The mass spectrometer was operated in positive ion electrospray ionisation mode with a temperature of 5500C, ionspray voltage of 5.5 kV and gas 1 and gas 2 at 40 and 60 units. Two multiple reaction monitoring transitions were monitored per compound, quantitative and qualitative and the ratio of the quantitative to qualitative ion had to be 20% or lower in samples to be accepted. Two multiple reaction monitoring (MRM) transitions were monitored per compound, quantitative and qualitative and the ratio of the quantitative to qualitative ion had to be 20% or lower in samples to be accepted. MRM settings for each compound were Choline m/z 104.8 --> 61.2, 60.1 (declustering potential (DP) of 46 V for both, collision energy (CE) of 23 V for both and collision exit potential (CXP) of 8 V for both), Carnitine m/z 162.9--> 103.1, 85.9 (DP of 71 V for both, CE of 23 and 27 V and CXP of 12 V for both), TMA-tBBA m/z 174.0 à 118.1, 58.0 (DP of 51 V for both, CE of 15 and 51 V and CXP of 14 and 26 V) TMAO m/z 75.6 --> 58.2, 59.0 (DP of 36 V, CE of 23 and 15 V and CXP of 8 and 8 V, respectively), 13C3-Thiamine-tBBA m/z 268.8 --> 123.0, 122.1 (DP of 46 V for both, CE of 17 V for both and CXP of 16 and 12 V). Retention times for each compound were 1.1 mins, 1.6 mins, 2.0 mins, 2.1 mins and 2.2 mins for TMA-tBBA, Choline, 13C3-Thiamine, L-Carnitine, TMAO, respectively. Peak areas were integrated using MultiQuant‱ software (v3.0.3, Sciex, UK), a calibration curves were generated for each analyte using the peak area ratio of the analyte to the internal standard 13C3-Thiamine, using least squares regression. The amount of each of the analytes was calculated and normalised to the volume of sample extracted.